Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease

NCT04988282 is registered in ClinicalTrials.gov with Turkish Thoracic Society as lead sponsor.

NCT NCT04988282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04988282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease
Lead sponsor
Turkish Thoracic Society
Phase
Phase 4
Overall status
Completed
Start date
May 24, 2021
Completion date
January 31, 2022
Enrollment
262 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, covid19, interstitial lung disease